Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
4
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
zolgensma
4
×
biogen
fda
gene therapy
glaxosmithkline
abbvie
amgen
avexis
brian kaspar
bristol-myers squibb
cancer immunotherapy
What
roundup
bio
news
biotech
nash
according
akcea
america
approval
august
biogen
biogen’s
biopharmaceutical
busy
cases
centers
cigarettes
companies
continues
control
convo
convoluted
days
deaths
decisions
democrats
devices
disease
dreams
drug
drugs
earlier
electronic
failures
fda
head
headaches
healthcare
holding
including
Language
unset
Current search:
zolgensma
×
biotech
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More